在11月8日第二屆進博會展示發布平臺上，科學服務領域的世界領導者——賽默飛世爾科技（以下簡稱賽默飛）發布了其全球首款能在一天內自動完成樣本制備到結果報告流程的高通量基因測序（NGS）平臺——Ion Torrent™ Genexus™系統，并發布了配套的Oncomine™ Precision Assay泛癌種試劑盒。
作為賽默飛全球第一套完全整合的高通量基因測序（NGS）平臺，Ion Torrent™ Genexus™系統提供了一天內、一站式的自動化整體解決方案，重新定義了基因組分析模式，為精準醫學在臨床中的進一步普及提供了可能。該平臺實現了僅需要少量樣本，就可以在一天內自動且經濟有效地完成從樣本到報告的完整基因測序流程。未來，該系統將助力更多醫院自建NGS檢測平臺，幫助癌癥等患者快速得到及時和全面的檢測結果，更好地指導靶向治療方案選擇，提升治療效果，改善患者預后。
Ion Torrent™ Genexus™ 系統
“兩屆進博會都為我們企業新品首發、供需對接搭建了非常好的平臺，這也是為什么我們會選擇第二屆進博會發布Ion Torrent™ Genexus™系統的原因。”賽默飛中國區總裁艾禮德（Tony Acciarito）表示：“我們希望通過一系列賽默飛前沿科技的發布，推進精準醫學在臨床中的應用，惠及更多中國患者，助力‘健康中國2030’目標的實現。”
Next-Generation Sequencing Platform - Ion Torrent™ Genexus System* by Thermo Fisher Scientific Makes its World Debut at the 2nd CIIE
Holds Potential to Advance Precision Medicine in the Clinic
During the 2nd CIIE, Thermo Fisher Scientific, the world leader in serving science, announced the launch of its Ion Torrent™ Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report workflow that delivers results economically in a single day. The company also introduced its oncomine Precision Assay*, an innovative pan-cancer panel for the Genexus platform. The two help win many audience’s attention, especially those from industry professionals.
As the first fully integrated NGS platform, Ion Torrent™ Genexus System features an one-stop automated specimen-to-report workflow that delivers results with practically zero intervention in a single day, redefining the genomic profiling paradigm, and enables a future in which local hospitals can adopt NGS and provide the most advanced care with all-around genomic information. We can now envision a time in which patients at local hospitals will have faster access to comprehensive test results that can guide more effective, targeted therapy selection and improved health outcomes.
Ion Torrent™ Genexus™ System
Tony Acciarito, President of Thermo Fisher Scientific China, mentioned that, “Both the first and second CIIEs provide a great platform for us as a company to launch our new products and exchange supply and demand, and that’s why we choose the 2nd CIIE to launch Ion Torrent™ Genexus System. We hope that Thermo Fisher’s leading innovative science can empower the clinical practice of precision medicines, bring benefits to more Chinese patients, and support the goal of ‘Healthy China 2030’.”
